|
Orphenadrine CitrateDrug - Orphenadrine Citrate The trade name of the product as shown on the labeling.
Dosage -
TABLET, EXTENDED RELEASE; ORAL
Active Ingredient(s) -
Orphenadrine Citrate
Strength -
100MG
Applicant -
WATSON LABS
New Drug Application (NDA) Number -
084303
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Watson Laboratories Inc
Orphenadrine Citrate
Orphenadrine Citrate 100mg Tablet, Extended Release; Oral
Orphenadrine Citrate 100mg Tablet, Extended Release; Oral Orphenadrine Citrate 100mg Tablet, Extended Release; Oral Orphenadrine Citrate 100mg Tablet, Extended Release; Oral Orphenadrine Citrate 100mg Tablet, Extended Release; Oral Orphenadrine Citrate 100mg Tablet, Extended Release; Oral Orphenadrine Citrate 100mg Tablet, Extended Release; Oral Orphenadrine Citrate 30mg/ml Injectable; Injection Orphenadrine Citrate 30mg/ml Injectable; Injection Norflex 100mg Tablet, Extended Release; Oral NewDrugInformation |